Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
01/05/1999 | US5856121 Nucleotide sequence |
01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
01/05/1999 | US5856091 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
01/05/1999 | US5855911 Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides |
01/05/1999 | CA2131415C Vector for liver-specific gene therapy |
01/03/1999 | CA2236462A1 Murc |
01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
01/01/1999 | CA2236459A1 Novel compounds |
01/01/1999 | CA2236452A1 Gida1 |
01/01/1999 | CA2236441A1 Gida2 |
01/01/1999 | CA2236435A1 Gida2 |
01/01/1999 | CA2236425A1 Gida1 |
01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
12/30/1998 | WO1998059064A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
12/30/1998 | WO1998059063A2 Bovine adenovirus type 3 genome |
12/30/1998 | WO1998059059A1 Expression system for production of therapeutic proteins |
12/30/1998 | WO1998059050A1 Cloning of a gene mutation for parkinson's disease |
12/30/1998 | WO1998058956A2 Methods for inducing an immune response involving prime-boost protocols |
12/30/1998 | WO1998058953A2 Surface exposed proteins from chlamydia pneumoniae |
12/30/1998 | WO1998058952A1 Angiotensin derivatives |
12/30/1998 | WO1998058944A1 Compositions and methods for activating genes of interest |
12/30/1998 | WO1998058630A1 Liposome-entrapped polynucleotide composition and method |
12/30/1998 | WO1998058629A2 Preparation of pharmaceutical compositions |
12/30/1998 | WO1998058542A1 A process of delivering a polynucleotide via the vascular system |
12/30/1998 | WO1998058541A1 Modulation of apoptosis |
12/30/1998 | EP0887416A2 Human AFC1 |
12/30/1998 | EP0887415A2 Human RCE1 |
12/30/1998 | EP0887414A2 Human serine proteases HGBAB90 |
12/30/1998 | EP0887413A2 Histidine kinase |
12/30/1998 | EP0887411A2 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) from Streptococcus pneumoniae |
12/30/1998 | EP0887408A1 Wnt-3 oncogene: polypeptides and polynucleotides |
12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
12/30/1998 | EP0887083A1 Device for injecting a material, especially a vaccine, into the pinna |
12/30/1998 | EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
12/30/1998 | EP0886679A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
12/30/1998 | EP0886651A1 Persephin and related growth factors |
12/30/1998 | EP0886650A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
12/30/1998 | EP0886646A1 Novel compounds |
12/30/1998 | EP0886642A1 Immune cell cytokine |
12/30/1998 | EP0750637B1 Dna encoding cai resistance proteins and uses thereof |
12/30/1998 | CN1203633A Diagnosis of susceptibility to cancer and treatment thereof |
12/30/1998 | CN1203632A P16 expression constructs and their application in cancer therapy |
12/30/1998 | CN1203630A 治疗和诊断组合物 Therapeutic and diagnostic compositions |
12/30/1998 | CN1203531A Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (GDNF) protein product |
12/30/1998 | CA2594375A1 Bovine adenovirus type 3 genome |
12/30/1998 | CA2294651A1 Surface exposed proteins from chlamydia pneumoniae |
12/30/1998 | CA2294611A1 Complexes for transporting nucleic acid into higher eukaryotic cells |
12/30/1998 | CA2294119A1 Expression system for production of therapeutic proteins |
12/30/1998 | CA2293833A1 Compositions and methods for activating genes of interest |
12/29/1998 | US5854224 Composition and method for delivery of nucleic acids |
12/29/1998 | US5854202 Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same |
12/29/1998 | US5854045 Transmembrane tyrosine phosphatase and methods of use thereof |
12/29/1998 | US5854038 Localization of a therapeutic agent in a cell in vitro |
12/29/1998 | US5854020 TCSTS polynucleotides |
12/29/1998 | US5854019 Cell-specific gene therapy using as promoter novel promoters for tissue inhibitors of metalloproteinase-3 |
12/29/1998 | US5853987 Decorin binding protein compositions and methods of use |
12/29/1998 | US5853976 Recombinant proteinase from clostridium histolyticum and its use for isolating cells and groups of cells |
12/29/1998 | US5853719 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
12/29/1998 | US5853717 Methods and compositions of growth control for cells encapsulated within bioartificial organs |
12/29/1998 | CA2096222C Bifunctional selectable fusion genes |
12/27/1998 | CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
12/26/1998 | CA2235778A1 Novel glmu |
12/24/1998 | DE19736198C1 Protease related protein |
12/24/1998 | DE19725186A1 Herz- und Skelettmuskel-spezifische Nukleinsäure, ihre Herstellung und Verwendung Heart and skeletal muscle-specific nucleic acid, their preparation and use |
12/24/1998 | CA2234418A1 Human afc1 |
12/24/1998 | CA2234402A1 Human rce1 |
12/23/1998 | WO1998057983A2 Mammalian neuro-growth factor like protein |
12/23/1998 | WO1998057664A1 Interleukin converting enzyme (ice) and central nervous system damage |
12/23/1998 | WO1998057663A1 Neural transplantation for treating neurological disease |
12/23/1998 | WO1998057662A2 Therapeutic systems |
12/23/1998 | WO1998057658A1 Compact epstein-barr virus replicons |
12/23/1998 | WO1998042830A3 Noey2 gene compositions and methods of use |
12/23/1998 | WO1998042320A3 Extension of the expression of transgenic proteins by immunomodulation with 15-deoxyspergualine |
12/23/1998 | EP0885966A2 Novel compouds |
12/23/1998 | EP0885965A2 Histidine kinase polypeptides |
12/23/1998 | EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide |
12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |
12/23/1998 | EP0885959A2 Human Wnt-5b protein |
12/23/1998 | EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator |
12/23/1998 | EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
12/23/1998 | EP0885901A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
12/23/1998 | EP0885307A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
12/23/1998 | EP0885306A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
12/23/1998 | EP0885297A1 Novel era |
12/23/1998 | EP0885237A1 Oligonucleotide analogues |
12/23/1998 | EP0885236A1 Oligonucleotide analogs |
12/23/1998 | EP0885002A2 Materials and methods for enhancing cellular internalization |
12/23/1998 | EP0884947A1 Dna vaccination for induction of suppressive t cell response |
12/23/1998 | CN1202936A Screening assay for compounds stimulating somatostatin and insulin production |
12/23/1998 | CN1202934A Delivery of biologically active polypeptides |
12/23/1998 | CN1202932A Therapeutic antiangiogenic compositions and methods |
12/23/1998 | CN1202931A Tumour vaccine and process for the preparation thereof |
12/23/1998 | CN1202900A Inhibition of tumor growth by antisense oligonucleotides for IL-8 and Il-8 receptor |
12/23/1998 | CN1202799A Method for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
12/23/1998 | CA2295439A1 Mammalian neuro-growth factor like protein |
12/23/1998 | CA2293299A1 Compact epstein-barr virus replicons |
12/23/1998 | CA2292608A1 Therapeutic systems for activation prodrugs |
12/22/1998 | US5852188 Oligonucleotides having chiral phosphorus linkages |
12/22/1998 | US5852173 TNF receptor death ligand proteins and inhibitors of ligand binding |